Patent Assignment
Reel/Frame 046559/0750
Assignment of Assignor's Interest
Recorded: 2018-08-06
Pages: 3
Assignor
DURING, MATTHEW
Executed: 2017-01-17
Assignee
OVID THERAPEUTICS INC.
1460 BROADWAY, NEW YORK, NEW YORK, 10036
Covered Properties
(4)
Formulations of Gaboxadol for Treatment of Angelman Syndrome, Fragile X Syndrome and Fragile X-Associated Tremor/Ataxia Syndrome
Application:
15/616,460 →
Publication:
US 2017/0348232
Methods of Treating Developmental Disorders with Gaboxadol
Application:
15/840,521 →
Publication:
US 2018/0098974
Methods of Treating Developmental Disorders with Gaboxadol
Application:
62/193,717 →
Formulations of Gaboxadol for Treatment of Angelman Syndrome, Fragile X Syndrome and Fragile X-Associated Tremor/Ataxia Syndrome
Application:
62/346,763 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 20, 2015
From: DURING, MATTHEW
To: OVID THERAPEUTICS INC.
Reel/Frame 036135/0379 →
Assignment of Assignor's Interest
Feb 1, 2017
From: DURING, MATTHEW
To: OVID THERAPEUTICS INC.
Reel/Frame 041146/0052 →
Assignment of Assignor's Interest
Dec 14, 2017
From: DURING, MATTHEW
To: OVID THERAPEUTICS INC.
Reel/Frame 044397/0753 →